Suchergebnisse - "Thuluvath, Paul J"

PubPharm (19)

1

HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics

enthalten in: Medicine | 2019

von Chehl, N. | Maheshwari, A. | Yoo, H. | +4

2

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy : An integrated analysis of HCV genotype 1-6 patients without cirrhosis

enthalten in: Journal of hepatology | 2018

von Puoti, M. | Foster, G. | Wang, S. | +16

3

Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2018

von Reddy, K. | Pol, S. | Thuluvath, P. | +18

4

Mental and physical health-related quality of life in patients with hepatitis C is related to baseline comorbidities and improves only marginally with hepatitis C cure

enthalten in: Clinical and translational gastroenterology | 2018

von Thuluvath, P. | Savva, Y.

5

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection

enthalten in: Annals of hepatology | 2016

von Rodriguez-Torres, M. | Lawitz, E. | Yangco, B. | +20

6

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Everson, G. | Sims, K. | Thuluvath, P. | +17

CommentIn: Liver Int. 2016 Feb;36(2):181-4. - PMID 26781595

7

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

enthalten in: The New England journal of medicine | 2015

von Feld, J. | Jacobson, I. | Hézode, C. | +103

CommentIn: N Engl J Med. 2016 Apr 28;374(17):1688-9

8

Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection : A Randomized Trial

enthalten in: Annals of internal medicine | 2015

von Everson, G. | Towner, W. | Davis, M. | +15

9

Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

enthalten in: Gastroenterology | 2015

von Lawitz, E. | Makara, M. | Akarca, U. | +10

10

A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

enthalten in: Journal of hepatology | 2015

von Hassanein, T. | Sims, K. | Bennett, M. | +16

CommentIn: J Hepatol. 2015 May;62(5):996-9. - PMID 25747660